UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer

Cancers, 2023-05, Vol.15 (11), p.2899

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy

Frontiers in oncology, 2024-02, Vol.14, p.1306311-1306311

2024

Link zum Volltext

Verfügbarkeit prüfen

Model of tumor dormancy/recurrence after short-term chemotherapy

PloS one, 2014-05, Vol.9 (5), p.e98021-e98021

2014

Link zum Volltext

Verfügbarkeit prüfen

Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis

Frontiers in oncology, 2024-06, Vol.14, p.1417175

2024

Link zum Volltext

Verfügbarkeit prüfen

Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma

Frontiers in oncology, 2022-08, Vol.12, p.959500-959500

2022

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways

Cancers, 2023-06, Vol.15 (13), p.3372

2023

Link zum Volltext

Verfügbarkeit prüfen

Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance

Breast cancer research : BCR, 2015-07, Vol.17 (1), p.91-91, Article 91

2015

Link zum Volltext

Verfügbarkeit prüfen

Gastric Mammalian Target of Rapamycin Signaling Regulates Ghrelin Production and Food Intake

Endocrinology (Philadelphia), 2009-08, Vol.150 (8), p.3637-3644

2009

Link zum Volltext

Verfügbarkeit prüfen

Circulating DNA in EGFR -mutated lung cancer

Annals of translational medicine, 2017-09, Vol.5 (18), p.379-379

2017

Link zum Volltext

Verfügbarkeit prüfen

Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis

Cancer medicine (Malden, MA), 2020-03, Vol.9 (6), p.2085-2095

2020

Link zum Volltext

Verfügbarkeit prüfen

First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non–Small Cell Lung Adenocarcinoma With a Novel Combination of Temozolomide and Lorlatinib: A Case Report

JTO clinical and research reports, 2023-07, Vol.4 (7), p.100536, Article 100536

2023

Link zum Volltext

Verfügbarkeit prüfen

Mutational profile, clinical characterization, and outcomes of lung cancer in solid organ transplant recipients

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21131-e21131

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparison of atezolizumab monotherapy to docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21157-e21157

2023

Link zum Volltext

Verfügbarkeit prüfen

Assessing the frequency of anemia evaluations in patients who are transfusion-dependent in an academic hematology and oncology practice

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24104-e24104

2023

Link zum Volltext

Verfügbarkeit prüfen

When not having a tissue may not be an issue in advanced lung cancer

Chinese Clinical Oncology, 2023-08, Vol.12 (4), p.32-32

2023

Link zum Volltext

Verfügbarkeit prüfen

Lung Cancer in Patients With Lynch Syndrome: Association or Coincidence?

Clinical lung cancer, 2023-11, Vol.24 (7), p.e237-e241

2023

Link zum Volltext

Verfügbarkeit prüfen

Incidence of additional primary malignancies in patients with malignant peritoneal mesothelioma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e20535-e20535

2023

Link zum Volltext

Verfügbarkeit prüfen

Retrospective analysis of the multikinase inhibitor (MKI) pazopanib in differentiated thyroid carcinoma (DTC) in the beyond-first-line setting

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18097-e18097

2023

Link zum Volltext

Verfügbarkeit prüfen

Association of docetaxel efficacy with cancer gene mutation status in patients with metastatic non-small-cell lung cancer who progressed on platinum doublets and immunotherapy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21030-e21030

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of immunotherapy cessation without disease progression on outcomes in patients with metastatic non-small cell lung cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21156-e21156

2023

Link zum Volltext

Verfügbarkeit prüfen

RefAI: a GPT-powered retrieval-augmented generative tool for biomedical literature recommendation and summarization

Journal of the American Medical Informatics Association : JAMIA, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

Circulating free DNA (cfDNA) for personalized treatment of lung cancer patients without cytopathologic diagnosis

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21143-e21143

2018

Link zum Volltext

Verfügbarkeit prüfen

Immune-Related Adverse Events in Patients with Lung Cancer

Current oncology reports, 2023-11, Vol.25 (11), p.1259-1275

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Englisch
(30)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(14)
Oncology
(14)
Lung Cancer
(6)
Chemotherapy
(5)
Humans
(5)
Immunotherapy
(5)
Cancer
(4)
Cancer Therapies
(4)
Health Aspects
(4)
Immune Checkpoint Inhibitors
(4)
Metastasis
(4)
Mutation
(4)
Non-Small Cell Lung Carcinoma
(4)
Nsclc
(4)
Patients
(4)
Small Cell Lung Carcinoma
(4)
Antineoplastic Agents - Pharmacology
(3)
Cell Line, Tumor
(3)
Female
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer

Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy

Model of tumor dormancy/recurrence after short-term chemotherapy

Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis

Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma

Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways

Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance

Gastric Mammalian Target of Rapamycin Signaling Regulates Ghrelin Production and Food Intake

Circulating DNA in EGFR -mutated lung cancer

Clinical Benefit from Docetaxel +/- Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy

Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis

First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non–Small Cell Lung Adenocarcinoma With a Novel Combination of Temozolomide and Lorlatinib: A Case Report

Mutational profile, clinical characterization, and outcomes of lung cancer in solid organ transplant recipients

Comparison of atezolizumab monotherapy to docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy

Assessing the frequency of anemia evaluations in patients who are transfusion-dependent in an academic hematology and oncology practice

When not having a tissue may not be an issue in advanced lung cancer

Lung Cancer in Patients With Lynch Syndrome: Association or Coincidence?

Incidence of additional primary malignancies in patients with malignant peritoneal mesothelioma

Retrospective analysis of the multikinase inhibitor (MKI) pazopanib in differentiated thyroid carcinoma (DTC) in the beyond-first-line setting

Association of docetaxel efficacy with cancer gene mutation status in patients with metastatic non-small-cell lung cancer who progressed on platinum doublets and immunotherapy

Effect of immunotherapy cessation without disease progression on outcomes in patients with metastatic non-small cell lung cancer

RefAI: a GPT-powered retrieval-augmented generative tool for biomedical literature recommendation and summarization

Circulating free DNA (cfDNA) for personalized treatment of lung cancer patients without cytopathologic diagnosis

Immune-Related Adverse Events in Patients with Lung Cancer

Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer

Suchergebnisse filtern